Paper Details

  1. Home
  2. Paper Details

Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.

Author: BanikNorbert, FielderKarin, HagedornCordula, KässnerFrank, NtampakasParis

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Patients with severe chronic obstructive pulmonary disease (COPD) often experience repeated exacerbations, leading to high healthcare costs. This study explored the potential of using a combined corticosteroid and bronchodilator inhaler to reduce exacerbations and improve patient compliance.
Paper Details　
Original Abstract of the Article :
Patients with severe or very severe chronic obstructive pulmonary disease (COPD) frequently suffer repeated exacerbations generating high health care utilization costs. Combined corticosteroid and bronchodilator treatment using a single inhaler might - via improved compliance - reduce exacerbation r...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.rmed.2012.12.020

データ提供：米国国立医学図書館（NLM）

A Race for Better COPD Management: Single vs. Separate Inhalers

Chronic obstructive pulmonary disease (COPD) is a debilitating lung disease that can significantly impact a person's quality of life. This study is like a race to find the most effective way to manage COPD, exploring the potential benefits of using a single inhaler for combined corticosteroid and bronchodilator treatment compared to separate inhalers. The study aims to improve treatment adherence and reduce exacerbations, which are periods of worsening COPD symptoms.

A Race for Better Adherence and Fewer Exacerbations

The study explores the potential benefits of using a single inhaler for combined corticosteroid and bronchodilator treatment, suggesting that [improved compliance might reduce exacerbation rates in COPD patients]. This concept is like finding a more efficient way to deliver water to a thirsty camel caravan, ensuring that everyone gets their share and stays hydrated.

A Glimmer of Hope for COPD Patients

This research offers a glimmer of hope for COPD patients. The study suggests that [a single-inhaler approach could lead to better adherence to treatment, resulting in fewer exacerbations and improved lung function], offering a potential path to a better quality of life for those living with COPD.

Dr. Camel's Conclusion

This research, like a camel trainer carefully selecting the most efficient equipment for a long desert journey, explores the potential of a single-inhaler approach for COPD management. The findings suggest that this strategy may lead to better outcomes for patients, offering a more convenient and effective way to navigate the challenges of this debilitating disease.

Date :
  1. Date Completed 2013-09-23
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

23337300

DOI: Digital Object Identifier

10.1016/j.rmed.2012.12.020

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.